2021
DOI: 10.3389/fmed.2021.746920
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic Reprogramming and Renal Fibrosis

Abstract: There are several causes of chronic kidney disease, but all of these patients have renal fibrosis. Although many studies have examined the pathogenesis of renal fibrosis, there are still no effective treatments. A healthy and balanced metabolism is necessary for normal cell growth, proliferation, and function, but metabolic abnormalities can lead to pathological changes. Normal energy metabolism is particularly important for maintaining the structure and function of the kidneys because they consume large amoun… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
24
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(24 citation statements)
references
References 177 publications
0
24
0
Order By: Relevance
“…Since HIF–1α is a transcriptional factor that promotes the expression of several genes involved in glycolysis [ 37 , 38 ], we next explored its levels in whole tissue lysates, observing that HIF–1α tends to increase along the UUO progression. However, a significant increase was observed only at 21 days of the UUO compared to the sham group ( Figure 6 C).…”
Section: Resultsmentioning
confidence: 99%
“…Since HIF–1α is a transcriptional factor that promotes the expression of several genes involved in glycolysis [ 37 , 38 ], we next explored its levels in whole tissue lysates, observing that HIF–1α tends to increase along the UUO progression. However, a significant increase was observed only at 21 days of the UUO compared to the sham group ( Figure 6 C).…”
Section: Resultsmentioning
confidence: 99%
“…Based on the circRNA-related regulatory network, we identified two hub genes, circSlc8a1 and circApoe, which might be involved in the pathogenesis of renal fibrosis by sponging multiple DE miRNAs and their downstream targeted DE mRNAs. Metabolic disturbance has been increasingly recognized as an important pathogenic process that underlies renal fibrosis, and development of drugs for metabolic reprogramming will be a promising anti-fibrotic therapy ( Zhao et al, 2020 ; Zhu et al, 2021 ). This study might provide a new perspective on renal fibrosis and contribute to the development of novel therapeutics for CKD.…”
Section: Discussionmentioning
confidence: 99%
“…Sirt1 has recently been found to act as an important regulator of immune cells and immune responses ( Shen et al, 2021 ), which deserves the attention of researchers studying kidney diseases. In addition, metabolic reprogramming has been an emerging hotspot of kidney disease research in recent years, and changes in fatty acid metabolism and glucose metabolism have been found to be closely related to renal fibrosis ( Zhu et al, 2021 ). Sirt1 plays an important role in energy and metabolic regulation ( Ong and Ramasamy, 2018 ), and therefore, sirt1 may mediate metabolic reprogramming and play an important role in renal diseases.…”
Section: Discussionmentioning
confidence: 99%